The genetic theory of infectious diseases: A brief history and selected illustrations

Annual Review of Genomics and Human Genetics

Volumn 14, Issue , 2013, Pages 215-243

  Casanova, Jean Laurent ^a,b   Abel, Laurent ^a,b  

^a ROCKEFELLER UNIVERSITY   (United States)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Human genetics of infectious diseases; Immunity to infection; Inborn errors of immunity; Pediatrics; Primary immunodeficiency

Indexed keywords

ALPHA INTERFERON; B LYMPHOCYTE RECEPTOR; CHEMOKINE RECEPTOR CCR5; ERYTHROCYTE MEMBRANE PROTEIN 1; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INOSITOL TRISPHOSPHATE 3 KINASE; INSULIN; INTERLEUKIN 28A; INTERLEUKIN 28B; INTERLEUKIN 29; MYELOID DIFFERENTIATION FACTOR 88; PENICILLIN DERIVATIVE; PHENYLALANINE; PHOSPHOLIPASE C GAMMA2; RIBAVIRIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TUBERCULIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3;

ADAPTIVE IMMUNITY; AGAMMAGLOBULINEMIA; ANTHRAX; ANTIBIOTIC RESISTANCE; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ASYMPTOMATIC INFECTION; AUTOSOMAL RECESSIVE INHERITANCE; BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; CHILDHOOD DISEASE; CHIRALITY; CLINICAL GENETICS; CONVERGENT EVOLUTION; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE SEVERITY; ENZYME REPLACEMENT; FERMENTATION; FEVER; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENE THERAPY; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; GERM THEORY OF DISEASE; GIARDIASIS; HEPATITIS C; HEREDITY; HERPES SIMPLEX ENCEPHALITIS; HUMAN; IMMUNE DEFICIENCY; INFECTION; INNATE IMMUNITY; LEISHMANIASIS; LEPROSY; LIFE EXPECTANCY; MALARIA; MALARIA FALCIPARUM; MICROBIAL GROWTH; MOLECULAR MECHANICS; MORTALITY; MUCOCUTANEOUS CANDIDIASIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PATHOGENICITY; PHAGOCYTE; PHENYLKETONURIA; PLASMODIUM VIVAX; POPULATION GENETICS; PRIMARY INFECTION; RECURRENT INFECTION; REVIEW; SCHISTOSOMIASIS; SECONDARY INFECTION; SERODIAGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT DURATION; UREAPLASMA INFECTION; VACCINATION; VACCINE FAILURE; VIBRIO CHOLERAE; VIRUS REPLICATION; X LINKED AGAMMAGLOBULINEMIA;

ALLERGY AND IMMUNOLOGY; ANIMALS; COMMUNICABLE DISEASES; GENETICS; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS;

EID: 84884310169     PISSN: 15278204     EISSN: 1545293X     Source Type: Book Series    
DOI: 10.1146/annurev-genom-091212-153448     Document Type: Review

References (177)

1. Abel L, Plancoulaine S, Jouanguy E, Zhang SY, Mahfoufi N, et al. 2010. Age-Dependent Mendelian predisposition to herpes simplex virus type 1 encephalitis in childhood. J. Pediatr. 157:623-29
2. Alcaís A, Abel L, Casanova JL. 2009. Human genetics of infectious diseases: Between proof of principle and paradigm. J. Clin. Investig. 119:2506-14
3. Alcaís A, Abel L, Casanova JL. 2010. Human genetics of infectious diseases. In Vogel and Motulsky's Human Genetics: Problems and Approache s, ed. MR Speiche r, SE Antonaraki s, AG Motulsk y, pp. 403-15. Berlin: Springer-Verlag. 4th ed.
4. Alcaís A, Alter A, Antoni G, Orlova M, Van Thuc N, et al. 2007. Stepwise replication identifies a low-producing lymphotoxin-A allele as a major risk factor for early-onset leprosy. Nat. Genet. 39: 517-22
5. Alcaís A, Quintana-Murci L, Thaler DS, Schurr E, Abel L, Casanova JL. 2010. Life-Threatening infectious diseases of childhood: Single-gene inborn errors of immunity? Ann. N. Y. Acad. Sci. 1214
6. Allison AC. 1954. Protection afforded by sickle cell trait against subtertian malarian infection. Br. Med. J. 1:290-94
7. Allison AC. 2002. The discovery of resistance to malaria of sickle-cell heterozygotes. Biochem. Mol. Biol. Educ. 30:279-87
8. Allison AC. 2009. Genetic control of resistance to human malaria. Curr. Opin. Immunol. 21:499-505
9. Audry M, Ciancanelli M, Yang K, Cobat A, Chang HH, et al. 2011. NEMO is a key component of NF-?B-And IRF-3-Dependent TLR3-mediated immunity to herpes simplex virus. J. Allergy Clin. Immunol. 128:610-17
10. Ayi K, Turrini F, Piga A, Arese P. 2004. Enhanced phagocytosis of ring-parasitizedmutant erythrocytes: A common mechanism that may explain protection against falciparum malaria in sickle trait and betathalassemia trait. Blood 104:3364-71
11. Balagopal A, Thomas DL, Thio CL. 2010. IL28B and the control of hepatitis C virus infection. Gastroenterology 139:1865-76
12. Bearn AG. 1993. Archibald Garrod and the Individuality of Man. Oxfor d, UK: Clarendon. 227 pp.
13. Bernard C. 1957. An Introduction to the Study of Experimental Medicine. New York: Dover. 226 pp.
14. Beutler B, Goodnow CC. 2011.Howhost defense is encoded in the mammalian genome. Mamm. Genome 22:1-5
15. Bibert S, Roger T, Calandra T, Bochud M, Cerny A, et al. 2013. IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction. J. Exp. Med. 210:1109-16
16. Blanco-Melo D, Venkatesh S, Bieniasz PD. 2012. Intrinsic cellular defenses against human immunodeficiency viruses. Immunity 37:399-411
17. Boehm T, McCurley N, Sutoh Y, Schorpp M, Kasahara M, Cooper MD. 2012. VLR-based adaptive immunity. Annu. Rev. Immunol. 30:203-20
18. Broides A, Yang W, Conley ME. 2006. Genotype/phenotype correlations in X-linked agammaglobulinemia. Clin. Immunol. 118:195-200
19. BrownM G, Dokun AO, Heusel JW, Smith HR, BeckmanD L, et al. 2001. Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292:934-37
20. Bruton OC. 1952. Agammaglobulinemia. Pediatrics 9:722-28
21. Bruton OC, Apt L, Gitlin D, Janeway CA. 1952. Absence of serum gamma globulins. AMA Am. J. Dis. Child. 84:632-36
22. Bunn HF. 2013. The triumph of good over evil: Protection by the sickle gene against malaria. Blood 121:20-25
23. Cairns J. 1997. Matters of Life and Death. Princeto n, NJ: Princeton Univ. Press. 257 pp.
24. Casadevall A, Pirofski L. 2001. Host-pathogen interactions: The attributes of virulence. J. Infect. Dis. 184:337-44
25. Casanova JL, Abel L. 2002. Genetic dissection of immunity to mycobacteria: The human model. Annu. Rev. Immunol. 20:581-620
26. Casanova JL, Abel L. 2004. The human model: A genetic dissection of immunity to infection in natural conditions. Nat. Rev. Immunol. 4:55-66
27. Casanova JL, Abel L. 2005. Inborn errors of immunity to infection: The rule rather than the exception. J. Exp. Med. 202:197-201
28. Casanova JL, Abel L. 2007. Human genetics of infectious diseases: A unified theory. EMBO J. 26:915-22
29. Casanova JL, Abel L. 2007. Primary immunodeficiencies: A field in its infancy. Science 317:617-19
30. Casanova JL, Abel L, Quintana-Murci L. 2011. Human TLRs and IL-1Rs in host defense: Natural insights from evolutionar y, epidemiologica l, and clinical genetics. Annu. Rev. Immunol. 29:447-91
31. Casanova JL, ConleyM E, Notarangelo LD. 2013. Inborn errors of immunity. In Fundamental Immunolog y, ed. WE Pau l, pp. 1235-66. Philadelphia: LippincottWilliams & Wilkins. 7th ed.
32. Casrouge A, Zhang SY, Eidenschenk C, Jouanguy E, Puel A, et al. 2006. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314:308-12
33. Chapman SJ, Hill AVS. 2012. Human genetic susceptibility to infectious disease. Nat. Rev. Genet. 13: 175-88
34. Cholera R, Brittain NJ, Gillrie MR, Lopera-Mesa TM, Diakite SA, et al. 2008. Impaired cytoadherence of Plasmodium falciparum-infected erythrocytes containing sickle hemoglobin. Proc. Natl. Acad. Sci. USA 105:991-96
35. Clark PJ, Thompson AJ. 2012. Host genomics and HCV treatment response. J. Gastroenterol. Hepatol. 27:212-22
36. Conley ME. 1985. B cells in patients with X-linked agammaglobulinemia. J. Immunol. 134:3070-74
37. Conley ME, Broides A, Hernandez-Trujillo V, Howard V, Kanegane H, et al. 2005. Genetic analysis of patients with defects in early B-cell development. Immunol. Rev. 203:216-34
38. Conley ME, Dobbs AK, Quintana AM, Bosompem A, Wang YD, et al. 2012. Agammaglobulinemia and absent B lineage cells in a patient lacking the p85asubunit of PI3K. J. Exp. Med. 209:463-70
39. Conley ME, Howard V. 2002. Clinical findings leading to the diagnosis of X-linked agammaglobulinemia. J. Pediatr. 141:566-71
40. Conley ME, Mathias D, Treadaway J, Minegishi Y, Rohrer J. 1998. Mutations in Btk in patients with presumed X-linked agammaglobulinemia. Am. J. Hum. Genet. 62:1034-43
41. Cook MC, Vinuesa CG, Goodnow CC. 2006. ENU-mutagenesis: Insight into immune function and pathology. Curr. Opin. Immunol. 18:627-33
42. Cooper MD, Lawton AR, Bockman DE. 1971. Agammaglobulinaemia with B lymphocytes. Specific defect of plasma-cell differentiation. Lancet 2:791-94
43. Currat M, Trabuchet G, Rees D, Perrin P, Harding RM, et al. 2002. Molecular analysis of the β-globin gene cluster in the Niokholo Mandenka population reveals a recent origin of the βS Senegal mutation. Am. J. Hum. Genet. 70:207-23
44. Davis LE, Bodian D, Price D, Butler IJ, Vickers JH. 1977. Chronic progressive poliomyelitis secondary to vaccination of an immunodeficient child. N. Engl. J. Med. 297:241-45
45. Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, et al. 1996. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Science 273:1856-62
46. De Kruif P. 1926. Microbe Hunters. New York: Blue Ribbon. 363 pp.
47. De Weers M, Verschuren MC, Kraakman ME, Mensink RG, Schuurman RK, et al. 1993. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiatio n, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. Eur. J. Immunol. 23:3109-14
48. Dobbs AK, Yang T, Farmer D, Kager L, Parolini O, Conley ME. 2007. Cutting edge: A hypomorphic mutation in Igβ(CD79b) in a patient with immunodeficiency and a leaky defect in B cell development. J. Immunol. 179:2055-59
49. Dubos RJ. 1950. Louis Pasteur: Free Lance of Science. Boston: Littl e, Brown. 418 pp.
50. Dubos RJ. 1955. Second thoughts on the germ theory. Sci. Am. 192:31-35
51. Dupuis S, Jouanguy E, Al-Hajjar S, Fieschi C, Al-Mohsen IZ, et al. 2003. Impaired response to interferon-A/βand lethal viral disease in human STAT1 deficiency. Nat. Genet. 33:388-91
52. FairhurstR M, Baruch DI, Brittain NJ, OsteraG R, Wallach JS, et al. 2005. Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria. Nature 435:1117-21
53. Fairhurst RM, Fujioka H, Hayton K, Collins KF, Wellems TE. 2003. Aberrant development of Plasmodium falciparum in hemoglobin CC red cells: Implications for the malaria protective effect of the homozygous state. Blood 101:3309-15
54. Falkow S. 1988. Molecular Koch's postulates applied to microbial pathogenicity. Rev. Infect. Dis. 10(Suppl. 2):S274-76
55. Farrar JE, Rohrer J, Conley ME. 1996. Neutropenia in X-linked agammaglobulinemia. Clin. Immunol. Immunopathol. 81:271-76
56. Feigin RD, Cherry JD. 1998. Textbook of Pediatric Infectious Diseases. Philadelphia: Saunders. 2,921 pp.
57. Ferrari S, Zuntini R, Lougaris V, Soresina A, Sourkova V, et al. 2007. Molecular analysis of the pre-BCR complex in a large cohort of patients affected by autosomal-recessive agammaglobulinemia. Genes Immun. 8:325-33
58. Furr PM, Taylor-Robinson D, Webster AD. 1994. Mycoplasmas and ureaplasmas in patients with hypogammaglobulinaemia and their role in arthritis: Microbiological observations over twenty years. Ann. Rheum. Dis. 53:183-87
59. Futatani T, Miyawaki T, Tsukada S, Hashimoto S, Kunikata T, et al. 1998. Deficient expression of Bruton's tyrosine kinase inmonocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 91:595-602
60. Futatani T, Watanabe C, Baba Y, Tsukada S, Ochs HD. 2001. Bruton's tyrosine kinase is present in normal platelets and its absence identifies patients with X-linked agammaglobulinaemia and carrier females. Br. J. Haematol. 114:141-49
61. Gad HH, Dellgren C, Hamming OJ, Vends S, Paludan SR, Hartmann R. 2009. Interferon-? is functionally an interferon but structurally related to the interleukin-10 family. J. Biol. Chem. 284:20869-75
62. Garrod AE. 1923. Inborn Errors of Metabolism. London: Henry Frowde and Hodder & Stoughton
63. Garrod AE. 1931. The Inborn Factors in Disease. Oxfor d, UK: Clarendon
64. Gaspar HB, Lester T, Levinsky RJ, Kinnon C. 1998. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): The use of protein analysis as a diagnostic indicator of XLA. Clin. Exp. Immunol. 111:334-38
65. Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, et al. 2009. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399-401
66. Geha RS, Rosen FS, Merler E. 1973. Identification and characterization of subpopulations of lymphocytes in human peripheral blood after fractionation on discontinuous gradients of albumin. The cellular defect in X-linked agammaglobulinemia. J. Clin. Investig. 52:1726-34
67. Guo B, Kato RM, Garcia-Lloret M, Wahl MI, Rawlings DJ. 2000. Engagement of the human pre-B cell receptor generates a lipid raft-Dependent calcium signaling complex. Immunity 13:243-53
68. Guo Y, Audry M, Ciancanelli M, Alsina L, Azevedo J, et al. 2011. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J. Exp. Med. 208:2083-98
69. HayesC N, Imamura M, Aikata H, ChayamaK. 2012. Genetics of IL28B andHCV-response to infection and treatment. Nat. Rev. Gastroenterol. Hepatol. 9:406-17
70. Herman M, Ciancanelli M, Ou YH, Lorenzo L, Klaudel-Dreszler M, et al. 2012. Heterozygous TBK1 mutations impair TLR3 immunity and underlie herpes simplex encephalitis of childhood. J. Exp. Med. 209:1567-82
71. Hill AVS. 2001. The genomics and genetics of human infectious disease susceptibility. Annu. Rev. Genomics Hum. Genet. 2:373-400
72. Hill AVS. 2006. Aspects of genetic susceptibility to human infectious diseases. Annu. Rev. Genet. 40:469-86
73. Hill AVS. 2012. Evolutio n, revolution and heresy in the genetics of infectious disease susceptibility. Philos. Trans. R. Soc. Lond. B 367:840-49
74. Hirano M, Das S, Guo P, Cooper MD. 2011. The evolution of adaptive immunity in vertebrates. Adv. Immunol. 109:125-57
75. Honda M, Sakai A, Yamashita T, Nakamoto Y, Mizukoshi E, et al. 2010. Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology 139:499-509
76. Howard V, Greene JM, Pahwa S, Winkelstein JA, Boyle JM, et al. 2006. The health status and quality of life of adults with X-linked agammaglobulinemia. Clin. Immunol. 118:201-8
77. Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P, et al. 2009. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat. Genet. 41:657-65
78. Janeway CA Jr, Medzhitov R. 2002. Innate immune recognition. Annu. Rev. Immunol. 20:197-216
79. Jouanguy E, Altare F, Lamhamedi S, Revy P, Emile JF, et al. 1996. Interferon-?-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N. Engl. J. Med. 335:1956-61
80. Kaufmann SH. 1994. Bacterial and protozoal infections in genetically disrupted mice. Curr. Opin. Immunol. 6:518-25
81. Kelly C, Klenerman P, Barnes E. 2011. Interferon lambdas: The next cytokine storm. Gut 60:1284-93
82. Koch R. 1882. Die Aetiologie der Tuberkulose. Berl. Klin. Wochenschr. 19:221-30
83. Kotenko SV, Gallagher G, Baurin VV, Lewis-Antes A, Shen M, et al. 2003. IFN-γs mediate antiviral protection through a distinct class II cytokine receptor complex. Nat. Immunol. 4:69-77
84. Ku CL, von Bernuth H, Picard C, Zhang SY, Chang HH, et al. 2007. Selective predisposition to bacterial infections in IRAK-4 deficient children: IRAK-4 dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 204:2407-22
85. Kuhn TS. 1962. The Structure of Scientific Revolutions. Chicago: Univ. Chicago Press. 172 pp.
86. Kurbanov F, Abdel-Hamid M, Latanich R, Astemborski J, Mohamed M, et al. 2011. Genetic polymorphism in IL28B is associated with spontaneous clearance of hepatitis C virus genotype 4 infection in an Egyptian cohort. J. Infect. Dis. 204:1391-94
87. Kwiatkowski DP. 2005. Howmalaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 77:171-92
88. Lafaille FG, Pessach IM, Zhang SY, Ciancanelli MJ, Herman M, et al. 2012. Impaired intrinsic immunity to HSV-1 in human iPSC-Derived TLR3-Deficient CNS cells. Nature 491:769-73
89. LaMonte G, Philip N, Reardon J, Lacsina JR, Majoros W, et al. 2012. Translocation of sickle cell erythrocyte microRNAs into Plasmodium falciparum inhibits parasite translation and contributes to malaria resistance. Cell Host Microbe 12:187-99
90. Landsteiner K. 1936. The Specificity of Serological Reactions. New York: Dover. 330 pp.
91. Lesh JE. 1984. Science and Medicine in France. The Emergence of Experimental Physiolog y, 1790-1855. Cambridg e, MA: Harvard Univ. Press. 276 pp.
92. Lichtenthaeler C. 1987. Geschichte derMedizin:Die Reihenfolge ihrer Epochen-Bilder und die treibendenKräfte ihrer Entwicklung: Ein Lehrbuch fu r̈ Studente n, Arzt e, Historike r, und geschichtlich Interessierte. Cologne: Deutscher A? rzte-Verlag
93. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, et al. 1996. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 86:367-77
94. LoGalbo PR, Sampson HA, Buckley RH. 1982. Symptomatic giardiasis in three patients with X-linked agammaglobulinemia. J. Pediatr. 101:78-80
95. López-Granados E, Pérez De Diego R, Ferreira Cerdán A, Fontán Casariego G, García RodriguezMC. 2005. A genotype-phenotype correlation study in a group of 54 patients with X-linked agammaglobulinemia. J. Allergy Clin. Immunol. 116:690-97
96. López-Granados E, Porpiglia AS, Hogan MB, Matamoros N, Krasovec S, et al. 2002. Clinical and molecular analysis of patients with defects in heavy chain gene. J. Clin. Investig. 110:1029-35
97. MacDonald A, Rocha JC, van Rijn M, Feillet F. 2011. Nutrition in phenylketonuria. Mol. Genet. Metab. 104(Suppl.):S10-18
98. Marcello T, Grakoui A, Barba-Spaeth G, Machlin ES, Kotenko SV, et al. 2006. Interferons a and γinhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics. Gastroenterology 131:1887-98
99. Marquet S, Abel L, Hillaire D, Dessein H, Kalil J, et al. 1996. Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat. Genet. 14:181-84
100. McKinney RE Jr, Katz SL, Wilfert CM. 1987. Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev. Infect. Dis. 9:334-56
101. Metchnikoff E 1933. Trois Fondateurs De La Médecine Moderne: Pasteu r, Liste r, Koch. Paris: Alcan. 195 pp.
102. Minegishi Y, Coustan-Smith E, Rapalus L, Ersoy F, Campana D, Conley ME. 1999. Mutations in Iga (CD80) result in a complete block in B-cell development. J. Clin. Investig. 104:1115-21
103. Minegishi Y, Coustan-Smith E, Wang YH, Cooper MD, Campana D, Conley ME. 1998. Mutations in the human γ5/14.1 gene result in B cell deficiency and agammaglobulinemia. J. Exp. Med. 187:71-77
104. Minegishi Y, Rohrer J, Coustan-Smith E, Lederman HM, Pappu R, et al. 1999. An essential role for BLNK in human B cell development. Science 286:1954-57
105. Min-Oo G, Gros P. 2005. Erythrocyte variants and the nature of their malaria protective effect. Cell Microbiol. 7:753-63
106. Mira MT, Alcaís A, Nguyen VT, Moraes MO, Di Flumeri C, et al. 2004. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 427:636-40
107. Mira MT, Alcaís A, Van Thuc N, Thai VH, Huong NT, et al. 2003. Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population. Nat. Genet. 33:412-15
108. Modiano D, Luoni G, Sirima BS, Simpore J, Verra F, et al. 2001. Haemoglobin C protects against clinical Plasmodium falciparum malaria. Nature 414:305-8
109. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, et al. 1996. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941-49
110. Nicolle C 1928. Investigations on typhus. http://www.nobelprize.org/ nobel-prizes/medicine/ laureates/1928/nicolle-lecture.html
111. Nicolle C. 1933. Les infections inapparentes. Scientia 33:181-271
112. Nicolle C. 1937. Destin des maladies infectieuses. Paris: Alcan. 301 pp.
113. Nomura K, Kanegane H, Karasuyama H, Tsukada S, Agematsu K, et al. 2000. Genetic defect in human X-linked agammaglobulinemia impedes a maturational evolution of pro-B cells into a later stage of pre-B cells in the B-cell differentiation pathway. Blood 96:610-17
114. Noordzij JG, De Bruin-Versteeg S, Comans-Bitter WM, Hartwig NG, Hendriks RW, et al. 2002. Composition of precursor B-cell compartment in bone marrow from patients with X-linked agammaglobulinemia compared with healthy children. Pediatr. Res. 51:159-68
115. Nunez C, Nishimoto N, Gartland GL, Billips LG, Burrows PD, et al. 1996. B cells are generated throughout life in humans. J. Immunol. 156:866-72
116. Olmsted JMD 1944. Fran'cois Magendie: Pioneer in Experimental Physiology and Scientific Medicine in 19th Century France. New York: Schuman's. 290 pp.
117. Orth G. 2008. Host defenses against human papillomaviruses: Lessons from epidermodysplasia verruciformis. Curr. Top. Microbiol. Immunol. 321:59-83
118. Pagliaccetti NE, Eduardo R, Kleinstein SH, Mu XJ, Bandi P, RobekMD. 2008. Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication. J. Biol. Chem. 283:30079-89
119. Pasteur L. 1922-1939. Maladies Virulente s, Virus-Vaccin s, Prophylaxie De La Rage. Paris: Masson et Cie
120. Pasteur L. 1922-1939. Oeuvres Complètes De Louis Pasteu r, Réunies par Pasteur Vallery-Radot. Ed. P Vallery-Radot. Paris: Masson et Cie
121. Pasteur L. 1926. Oeuvres Complètes De Louis Pasteu r, Reúnies par Pasteur Vallery-Radot. Vol. 4: Etudes sur la Maladie des Versà Soie. Ed. P Vallery-Radot. Paris: Masson et Cie
122. Pasvol G, Weatherall DJ, Wilson RJ. 1978. Cellular mechanism for the protective effect of haemoglobin S against P. falciparum malaria. Nature 274:701-3
123. Pearson K. 1912. Tuberculosi s, Heredity and Environment. Eugen. Lab. Lect. Ser. VIII. London: Dulau. 46 pp.
124. Pedergnana V, Abdel-Hamid M, Guergnon J, Mohsen A, Le Fouler L, et al. 2012. Analysis of IL28B variants in an Egyptian population defines the 20 kilobases minimal region involved in spontaneous clearance of hepatitis C virus. PLoS ONE 7:e38578
125. Pérez De Diego R, Sancho-Shimizu V, Lorenzo L, Puel A, Plancoulaine S, et al. 2010. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33:400-11
126. Picard C, Casanova JL, Abel L. 2006. Mendelian traits that confer predisposition or resistance to specific infections in humans. Curr. Opin. Immunol. 18:383-90
127. Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, et al. 2003. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299:2076-79
128. Picard C, von Bernuth H, Ghandil P, Chrabieh M, Levy O, et al. 2010. Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine 89:403-25
129. Plebani A, Soresina A, Rondelli R, Amato GM, Azzari C, et al. 2002. Clinica l, immunologica l, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: An Italian multicenter study. Clin. Immunol. 104:221-30
130. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282:2085-88
131. Preud'Homme JL, Griscelli C, Seligmann M. 1973. Immunoglobulins on the surface of lymphocytes in fifty patients with primary immunodeficiency diseases. Clin. Immunol. Immunopathol. 1:241-56
132. Prokunina-Olsson L, Muchmore B, Tang W, Pfeiffer RM, Park H, et al. 2013. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat. Genet. 45:164-71
133. Puffer R. 1944. Familial Susceptibility to Tuberculosis: Its Importance as a Public Health Problem. Cambridg e, MA: Harvard Univ. Press. 106 pp.
134. Quartier P, Foray S, Casanova JL, Hau-Rainsard I, Blanche S, Fischer A. 2000. Enteroviral meningoencephalitis in X-linked agammaglobulinemia: Intensive immunoglobulin therapy and sequential viral detection in cerebrospinal fluid by polymerase chain reaction. Pediatr. Infect. Dis. J. 19:1106-8
135. Quintana-Murci L, Alcaïs A, Abel L, Casanova JL. 2007. Immunology in natura: Clinica l, epidemiological and evolutionary genetics of infectious diseases. Nat. Immunol. 8:1165-71
136. Rauch A, Kutalik Z, Descombes P, Cai T, Di Iulio J, et al. 2010. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: A genome-wide association study. Gastroenterology 138:1338-45
137. Rawlings DJ. 1999. Bruton's tyrosine kinase controls a sustained calcium signal essential for B lineage development and function. Clin. Immunol. 91:243-53
138. Robek MD, Boyd BS, Chisari FV. 2005. Lambda interferon inhibits hepatitis B and C virus replication. J. Virol. 79:3851-54
139. Roifman CM, Rao CP, Lederman HM, Lavi S, Quinn P, Gelfand EW. 1986. Increased susceptibility to Mycoplasma infection in patients with hypogammaglobulinemia. Am. J. Med. 80:590-94
140. Roth EF Jr, Friedman M, Ueda Y, Tellez I, Trager W, Nagel RL. 1978. Sickling rates of human AS red cells infected in vitro with Plasmodium falciparum malaria. Science 202:650-52
141. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, et al. 1996. Resistance to HIV-1 infection in Caucasian individuals bearingmutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-25
142. Sancho-Shimizu V, Pérez De Diego R, Jouanguy E, Zhang SY, Casanova JL. 2011. Inborn errors of anti-viral interferon immunity in humans. Curr. Opin. Virol. 1:487-96
143. Sancho-Shimizu V, Pérez De Diego R, Lorenzo L, Halwani R, Alangari A, et al. 2011. Herpes simplex encephalitis in children with autosomal recessive and dominant TRIF deficiency. J. Clin. Investig. 121:4889-902
144. Sancho-Shimizu V, Zhang SY, Abel L, Tardieu M, Rozenberg F, et al. 2007. Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans. Curr. Opin. Allergy Clin. Immunol. 7:495-505
145. Saouaf SJ, Mahajan S, Rowley RB, Kut SA, Fargnoli J, et al. 1994. Temporal differences in the activation of three classes of non-Transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. Proc. Natl. Acad. Sci. USA 91:9524-28
146. Segal AW. 2005. How neutrophils kill microbes. Annu. Rev. Immunol. 23:197-23
147. Shebl FM, Maeder D, Shao Y, Prokunina-Olsson L, Schadt EE, O'Brien TR. 2010. In the absence of HCV infectio n, interferon stimulated gene expression in liver is not associated with IL28B genotype. Gastroenterology 139:1422-24
148. Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, et al. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat. Immunol. 4:63-68
149. Siegal FP, Pernis B, Kunkel HG. 1971. Lymphocytes in human immunodeficiency states: A study of membrane-Associated immunoglobulins. Eur. J. Immunol. 1:482-86
150. Silverstein AM. 1989. A History of Immunology. San Diego: Academic. 422 pp.
151. Smith CI, Baskin B, Humire-Greiff P, Zhou JN, Olsson PG, et al. 1994. Expression of Bruton's agammaglobulinemia tyrosine kinase gen e, BT K, is selectively down-regulated in T lymphocytes and plasma cells. J. Immunol. 152:557-65
152. Smith T. 1934. Parasitism and Disease. Princeto n, NJ: Princeton Univ. Press
153. Staeheli P, Haller O, Boll W, Lindenmann J, Weissmann C. 1986. Mx protein: Constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 44:147-58
154. Sun K, Metzger DW. 2008. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat. Med. 14:558-64
155. Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, et al. 2009. IL28B is associated with response to chronic hepatitis C interferon-Aand ribavirin therapy. Nat. Genet. 41:1100-4
156. Tan X, Traore B, Kayentao K, Ongoiba A, Doumbo S, et al. 2011. Hemoglobin S and C heterozygosity enhances neither the magnitude nor breadth of antibody responses to a diverse array of Plasmodium falciparum antigens. J. Infect. Dis. 204:1750-61
157. Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, et al. 2009. Genome-wide association of IL28B with response to pegylated interferon-Aand ribavirin therapy for chronic hepatitis C. Nat. Genet. 41:1105-9
158. Tauber AI, Chernyak L. 1991. Metchnikoff and the Origins of Immunology. Oxfor d, UK: Oxford Univ. Press. 247 pp.
159. Taylor SM, Parobek CM, Fairhurst RM. 2012. Haemoglobinopathies and the clinical epidemiology of malaria: A systematic review and meta-Analysis. Lancet Infect. Dis. 12:457-68 160
160. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, et al. 2009. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461:798-801
161. Timmann C, Thye T, Vens M, Evans J, May J, et al. 2012. Genome-wide association study indicates two novel resistance loci for severe malaria. Nature 489:443-46
162. Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, et al. 1993. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72:279-90
163. Urban TJ, Thompson AJ, Bradrick SS, Fellay J, Schuppan D, et al. 2010. IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. Hepatology 52:1888-96
164. Valiaho J, Smith CI, Vihinen M. 2006. BTKbase: The mutation database for X-linked agammaglobulinemia. Hum. Mutat. 27:1209-17
165. Vallery-Radot R. 1926. The Life of Pasteur. Garden Cit y, NY: Garden City Publ. 484 pp.
166. van Zelm MC, Geertsema C, Nieuwenhuis N, De Ridder D, Conley ME, et al. 2008. Gross deletions involving IGH M, BT K, or Artemis: A model for genomic lesions mediated by transposable elements. Am. J. Hum. Genet. 82:320-32
167. Vetrie D, Vorechovsky I, Sideras P, Holland J, Davies A, et al. 1993. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-Tyrosine kinases. Nature 361:226-33
168. Vidal SM, Malo D, Marquis JF, Gros P. 2008. Forward genetic dissection of immunity to infection in the mouse. Annu. Rev. Immunol. 26:81-132
169. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. 1993. Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg. Cell 73:469-85
170. von Bernuth H, Picard C, Jin Z, Pankla R, Xiao H, et al. 2008. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321:691-96
171. Williams TN. 2011. How do hemoglobins S and C result in malaria protection? J. Infect. Dis. 204: 1651-53
172. Williams TN, Mwangi TW, Roberts DJ, Alexander ND, Weatherall DJ, et al. 2005. An immune basis for malaria protection by the sickle cell trait. PLoS Med. 2:e128
173. Winkelstein JA, Marino MC, Lederman HM, Jones SM, Sullivan K, et al. 2006. X-linked agammaglobulinemia: Report on a United States registry of 201 patients. Medicine 85:193-202
174. Yel L, Minegishi Y, Coustan-Smith E, Buckley RH, Trubel H, et al. 1996. Mutations in the mu heavychain gene in patients with agammaglobulinemia. N. Engl. J. Med. 335:1486-93
175. Zhang F, Huang W, Chen S, Sun L, Liu H, et al. 2009. Genomewide association study of leprosy. N. Engl. J. Med. 361:2609-18
176. Zhang F, Liu H, Chen S, Low H, Sun L, et al. 2011. Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. Nat. Genet. 43:1247-51
177. Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, et al. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522-27